Abacavir For HIV (Ziagen): A Comprehensive Guide
Comprehensive guide to Abacavir (Ziagen): uses, dosage, side effects, and key safety information for HIV treatment.
Abacavir, marketed as Ziagen, is a prescription antiretroviral medication used in combination with other drugs to treat human immunodeficiency virus (HIV) infection in adults, adolescents, and children.
About abacavir
Abacavir belongs to a class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs). It works by interfering with the HIV replication process, specifically by blocking the reverse transcriptase enzyme that the virus uses to convert its RNA into DNA within infected cells. This action reduces the viral load in the blood, increases CD4 cell counts, and helps preserve immune function, though it does not cure HIV or prevent transmission.
Clinical studies involving over 1,800 HIV-infected adults demonstrated that abacavir, alone or in combination with drugs like lamivudine and zidovudine, was more effective than placebo at controlling HIV and comparable to other antivirals. Pediatric studies in children aged 3 months to 18 years also showed efficacy when combined with other therapies.
Before taking abacavir
Allergies
Do not take abacavir if you are allergic to abacavir or any ingredients in the tablets or oral solution. Severe allergic reactions, including life-threatening hypersensitivity, have been reported.
HLA-B*5701 screening
Before starting abacavir, all patients must be screened for the HLA-B*5701 allele, regardless of ethnicity. Abacavir is contraindicated in those who test positive for this genetic marker due to a significantly increased risk of hypersensitivity reactions. This screening is mandatory as per EMA and other guidelines.
Other medicines
Inform your doctor about all medications, including prescription, over-the-counter, herbal supplements, and vaccines. Abacavir may interact with drugs metabolized by certain enzymes, potentially altering efficacy or increasing side effects. It is used only in combination antiretroviral therapy.
Pregnancy and breastfeeding
Abacavir is used during pregnancy if benefits outweigh risks; animal studies show no direct harm, but human data are limited. Effective contraception is advised. It is present in breast milk, so breastfeeding is not recommended for HIV-positive mothers to avoid transmission risk.
Babies and children
Safe and effective for children aged 3 months and older. Dosing is weight-based. Not studied in infants under 3 months or elderly over 65.
Medical history
Discuss liver disease (especially hepatitis B), kidney issues, heart conditions, or prior hypersensitivity reactions. Dose adjustments may be needed for mild hepatic impairment.
How and when to take abacavir
Dosage
Adults and adolescents: 600 mg daily (as 300 mg twice daily or 600 mg once daily).
Children (3 months and older): 16 mg/kg/day (max 600 mg), divided as twice daily or once daily based on formulation.
Forms available
- 300 mg tablets
- Oral solution: 20 mg/mL (strawberry/banana flavor, may darken over time)
How to take
Take orally with or without food. Tablets can be swallowed whole; do not chew. Shake oral solution well. If a dose is missed, take it as soon as remembered unless close to next dose—do not double up.
How long to take
Lifelong, as part of combination therapy, unless discontinued due to side effects, resistance, or physician advice. Continuous use is essential to maintain viral suppression.
Side effects of abacavir
Common side effects include nausea, vomiting, diarrhea, headache, fatigue, and rash. Most are mild and resolve over time.
Serious side effects
Hypersensitivity reaction: Occurs in up to 8% of patients; symptoms include fever, rash, fatigue, nausea, vomiting, diarrhea, abdominal pain, sore throat, cough, and shortness of breath. Can be fatal if drug is continued. Stop immediately and seek emergency care. Risk highest in HLA-B*5701 carriers.
Lactic acidosis and severe hepatomegaly: Rare but serious; symptoms include muscle pain, breathing difficulty, dizziness, cold feeling, irregular heartbeat, nausea, vomiting, stomach pain, dark urine, jaundice.
Hepatitis B exacerbation: Upon discontinuation in co-infected patients.
Immune Reconstitution Syndrome: When CD4 counts rise.
| Adverse Reaction | Frequency (Abacavir Arm) | Control Arm |
|---|---|---|
| Nausea | 19% | 17% |
| Headache | 13% | 9% |
| Vomiting | 9% | 2% |
| Bronchitis | 4% | 5% |
Data from clinical trials (CNA3005).
Reporting side effects
Report suspected side effects to your doctor or national reporting systems.
Cautions when taking abacavir
- Carry a hypersensitivity warning card.
- Regular monitoring of viral load, CD4 count, liver/kidney function, and lipids.
- Avoid alcohol excess; monitor for fat redistribution or immune issues.
- Do not share medication.
Common questions about abacavir
How does abacavir work?
As an NRTI, it mimics nucleosides to terminate viral DNA chain elongation.
Is abacavir a cure for HIV?
No, it manages the virus but does not eradicate it.
What if I miss a dose?
Take as soon as possible; resume schedule.
Can abacavir be taken once daily?
Yes, 600 mg once daily is as effective as twice daily in studies.
What are signs of hypersensitivity?
Fever, rash, GI symptoms, respiratory issues—stop drug immediately.
Interactions
Potential interactions with methadone, ethanol, and CYP-metabolized drugs. Monitor levels.
Further information
Consult healthcare provider for personalized advice. Patient leaflets available from manufacturers.
References
- Ziagen | European Medicines Agency (EMA) — EMA. 2023. https://www.ema.europa.eu/en/medicines/human/EPAR/ziagen
- abacavir (Ziagen) – International Association of Providers of AIDS Care — IAPAC. 2023. https://www.iapac.org/fact-sheet/abacavir-brand-name-ziagen/
- Abacavir (Ziagen) Tablets: Uses & Side Effects — Cleveland Clinic. 2024. https://my.clevelandclinic.org/health/drugs/18032-abacavir-tablets
- Abacavir (Ziagen) – HIV/HCV Medication Guide — HIV Medication Guide. 2019. https://www.hivmedicationguide.com/wp-content/uploads/2019/06/abacavir.pdf
- Abacavir Ziagen – Treatment — University of Washington. 2024. https://www.hivprep.uw.edu/page/treatment/drugs/abacavir
- ZIAGEN (abacavir) tablets and oral solution — ViiV Healthcare. 2023. https://viivhealthcare.com/content/dam/cf-viiv/viiv-healthcare/en_AU/Ziagen_PI_015_Approved.pdf
- Abacavir – StatPearls — NCBI Bookshelf. 2023-10-01. https://www.ncbi.nlm.nih.gov/books/NBK537117/
Similar Articles
Read full bio of Sneha Tete
